发明名称 |
COMMINUTED FORM OF 3-{4-[2-(4-<i>TERT</i>-BUTOXYCARBONYLAMINOPHENYL)ETHOXY]PHENYL}-(S)-2-ETHOXY PROPANOIC |
摘要 |
The present invention relates to a reduced particle size form of the compound 3-{4-[2-(4-<i>tert</i>-butoxycarbonylaminophenyl)ethoxy]phenyl}-(S)-2-ethoxy propanoic acid, as shown in formula (I), or a pharmaceutically acceptable salt thereof or a solvate of either thereof. The invention also concerns methods of treating one or more conditions associated with Insulin Resistance Syndrome using the reduced particle size form of the compound, or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for use in one or more of said conditions. The invention further concerns pharmaceutical compositions containing the reduced particle size form of the compound, or a pharmaceutically acceptable salt thereof, or a solvate thereof, as an active ingredient, as well as processes for the manufacture of the reduced particle size form of the compound, or a pharmaceutically acceptable salt thereof.
|
申请公布号 |
WO0140166(A1) |
申请公布日期 |
2001.06.07 |
申请号 |
WO2000SE02380 |
申请日期 |
2000.11.29 |
申请人 |
ASTRAZENECA AB;HALLGREN, AGNETA;ROOS, KRISTINA |
发明人 |
HALLGREN, AGNETA;ROOS, KRISTINA |
分类号 |
A61K9/14;A61K31/27;C07C271/28;(IPC1-7):C07C271/28;A61K31/325;A61P3/00;A61P5/48 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|